EP4089174A4
(en )
2023-08-02
Engineered immune cell and use thereof
EP3964238A4
(en )
2022-09-14
Bcma-targeting engineered immune cell and use thereof
EP3775228A4
(en )
2022-02-23
Engineered immune effector cells and use thereof
EP4125948A4
(en )
2024-05-29
Mitochondria-enriched genetically engineered cells and uses thereof
EP3822345A4
(en )
2022-06-29
Genetically engineered cell and application thereof
SG11202111679XA
(en )
2021-11-29
Engineered cells and uses thereof
EP4165049A4
(en )
2024-09-11
Isotryptamine psychoplastogens and uses thereof
CA3258547A1
(en )
2023-12-21
Engineered immune cells
EP4021465A4
(en )
2023-02-22
Engineered immune cells
GB202000934D0
(en )
2020-03-04
Engineered immune cells
GB202118201D0
(en )
2022-01-26
Engineered immune cell
EP3931216A4
(en )
2023-04-19
Engineered immune cells
HK40101165A
(en )
2024-05-10
Engineered immune cells and uses thereof
EP4257676A4
(en )
2025-02-26
Modified immune cell and use thereof
HK40109954A
(en )
2024-12-13
Nr4a3-deficient immune cells and uses thereof
HK40115270A
(en )
2025-03-28
Nr4a3-deficient immune cells and uses thereof
CA3270561A1
(en )
2024-04-18
Modified immune cells and uses thereof
HK40098659A
(en )
2024-04-05
Genetically engineered cells and uses thereof
HK40103060A
(en )
2024-06-21
Genetically engineered cells and uses thereof
EP4045670A4
(en )
2023-11-08
Genetically engineered yeast cells and methods of use thereof
HK40123290A
(en )
2025-10-17
Engineered immune cells
HK40096687A
(en )
2024-02-23
Engineered ipsc and persistent immune effector cells
EP4440597A4
(en )
2025-11-12
Engineered cells and uses thereof
HK40097201A
(en )
2024-03-08
Engineered ipsc and persistent immune effector cells
HK40085182A
(en )
2023-07-28
Mitochondria-enriched genetically engineered cells and usesthereof